Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced 'robust' immune response - CNBC

1. Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced 'robust' immune response  CNBC
2. Moderna coronavirus vaccine shows 'promising' safety and immune response results in published Phase 1 study, but more research is needed  CNN
3. Fauci: Coronavirus vaccine possible by the end of the year  Reuters
4. First COVID-19 vaccine tested in US poised for final testing  The Associated Press
5. Experimental COVID-19 vaccine safe, generates immune response | National Institutes of Health  National Institutes of Health
6. View Full Coverage on Google News

by via Top stories - Google News